u
uniQure
Amsterdam, Netherlands
Founded 1998 NASDAQ: QURE
Nanomedicine Gene Therapy Delivery Nanobiosensors Cell Therapy Nano Protein Nanoparticles Drug Delivery
About
Gene therapy company developing AAV-based treatments for severe genetic diseases
Company Details
- Type
- public
- Employees
- 500+
- Funding
- Public
Key Products
- Hemgenix
- AMT-130
- AMT-191